News
Congratulations to Toni: Recipient of the 2026 NIPTE Rigaku Summer Research Scholarship
Saturday, June 20, 2026
Congratulations to Toni, who was named the 2026 NIPTE Rigaku Summer Research Scholar!
New publication: Advancing understanding of mini-tablet compaction mechanics
Thursday, June 18, 2026
Our new study published in Pharmaceutical Research uses DEM simulations to uncover how particle-level force distribution governs mini-tablet compaction performance.
New publication: Soluplus-based amorphous dispersions reveal optimal drug loading for enhanced dissolution performance
Friday, February 6, 2026
Our new publication in Journal of Pharmaceutical Sciences shows how drug loading impacts dissolution and supersaturation, guiding better design of amorphous drug formulations.
Dr. Hiew receives the 2025 Ebert Prize
Friday, March 28, 2025
Dr. Hiew was recognized as the 2025 Ebert Prize winner at the 2025 American Pharmacists Association Annual Meeting & Exposition in Nashville, Tennessee.
Bien named a recipient of the 2025 MATFab Seed Grant Award
Thursday, January 23, 2025
Bien received the 2025 MATFab Seed Grant Award to support his research.
Bharathi elected to Student Chapter committee
Wednesday, December 4, 2024
Congratulations to Bharathi, who was recently elected to the University of Iowa AAPS Student Chapter committee!
Our lab receives funding from the U.S. National Science Foundation
Monday, November 25, 2024
Dr. Hiew received fellowship from the U.S. National Science Foundation.
New lab member: Toni Koopmeiners
Wednesday, October 9, 2024
A warm welcome to Toni who recently joined the lab!
New editorial: Choosing a career path
Wednesday, August 21, 2024
Dr. Hiew recently penned an editorial entitled "A Pharmaceutical Scientist’s Journey: My Path to an Academic Career", which was published in Molecular Pharmaceutics.
New publication: Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023
Saturday, June 1, 2024
Our review entitled "Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023" was recently accepted for publication in the International Journal of Pharmaceutics: X.
Pagination